Strategic Partnerships Opportunity to explore co-development or distribution agreements with system integrators and research infrastructure providers (e.g., Silicon Mechanics) to scale knoSYS100 deployments in labs and academic settings, leveraging existing sales channels and technical support capabilities.

Genomics Platform Target pharmaceutical and academic research organizations seeking end-to-end genome interpretation for exomes and genomes; position knomeDISCOVERY and knoSYS as integrated workflow solutions to shorten study timelines and improve interpretation accuracy.

Early Stage Growth Despite small current revenue, Knome has substantial funding and a notable acquisition history; pursue enterprise deals with biotech startups and CROs looking for scalable interpretation software, offering pilot programs or tiered licenses to accelerate adoption.

Leadership & Legacy Leverage recognition from founders and industry ties (e.g., Harvard genetics pedigree) to engage with academic institutions and grant-funded research programs, framing Knome as a trusted partner for genome interpretation initiatives.

Market Expansion Expand from niche labs to larger genomics service providers by highlighting reliability, end-to-end decision support, and cloud-enabled workflows; align with customers who require scalable cloud or on-premise deployment at varying data governance levels.